These results suggest that PET imaging with 18F-DOPA and 11C-PK11195 could help identify NMCs with ongoing nigrostriatal pathology and show that at least in some cases, neuroinflammation could play a role in the pathophysiology of early phases of LRRK2-PD. This evidence concerns the gene LRRK2 and Parkinson disease.